Dapagliflozin for reducing inflammation in sepsis
Part of Infections clinical trials.
This study tests whether a medicine called dapagliflozin can help reduce inflammation in people with sepsis (a serious blood infection that can cause organ failure). It focuses on a protein in the blood that controls inflammation and might improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- In the ICU with a diagnosis of sepsis, or developed sepsis while in the ICU
- Not pregnant or breastfeeding
- No known allergy to dapagliflozin
- No current shock (septic or other)
- No severe kidney disease requiring dialysis
- No type 1 diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of diabetes medicine (SGLT2 inhibitors) can help adults with sepsis, a life-threatening response to infection. If you have new-onset sepsis and can take oral medicine, you may be eligible.
This study tests whether a medication called dapagliflozin (normally used for diabetes and heart failure) can help improve blood flow in small vessels (microcirculation) for people in septic shock, a life-threatening condition caused by severe infection. If the medication works, it may help restore normal blood flow and improve recovery.
This study tests a medication called dapagliflozin to see if it can reduce inflammation and improve red blood cell and iron levels in people with type 2 diabetes and chronic kidney disease.
This trial tests whether a diabetes drug called dapagliflozin can help people on peritoneal dialysis keep their remaining kidney function longer. It is for patients who started dialysis recently and still make urine.
This trial tests whether a diabetes medicine called dapagliflozin can help improve anemia (low red blood cell count) in people with lower-risk myelodysplastic syndromes. Myelodysplastic syndromes are a group of blood disorders where the bone marrow doesn't make enough healthy blood cells. The study aims to see if this drug can help you feel better by boosting your blood counts.
This study tests a medication called dapagliflozin (a drug used for diabetes) to see if it can help people with advanced liver disease and fluid build-up in the belly that does not go away with standard care. It may offer a new way to manage this difficult condition.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.